Search Press releases Keywords From To 20 Oct 2004 UCB confirms third quarter Zyrtec sales in the US / 6% Increase in European Allergy Franchise Read More 18 Oct 2004 UCB appoints Chief Financial Officer Read More 1 Oct 2004 UCB sells Surface Specialties to Cytec for € 1.5 billion Read More 30 Sep 2004 UCB: Closing of the sale of its films business Read More 21 Sep 2004 UCB Pharma outlines positive preliminary results from second pivotal CDP 870 Phase III trial in rheumatoid arthritis Read More 3 Sep 2004 Georges Jacobs announces that he will resign from his executive post on January 1, 2005 Read More Pagination First page Previous page Previous … Page 193 Page 194 Page 195 Page 196 Current page 197 Page 198 Page 199 Page 200 Page 201 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
